Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1425 participants.

Also called NCT05027984

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,425 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
Registry
  • NCT NCT05027984
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Greece, Italy, Spain, Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05027984. Randomized; single masking; primary purpose treatment. Start 2021-06-30 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
Acronym
INTERCLIMA
Condition
Coronary Disease
Condition
Ischemic Heart Disease
Intervention (Device)
Optical coherence tomography
Intervention (Device)
iFR/FFR/RFR
Lead sponsor
Centro per la Lotta Contro l'Infarto - Fondazione Onlus (class: other)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct05027984
Content hash
e2d713b03afe493f13052f59cf5361aaa1436ebc996e1ad8bf309704e0ddadef